# A Study of HSK21542 in a Peritoneal Dialysis Pruritus Population.

> **NCT06290375** · PHASE2 · UNKNOWN · sponsor: **Xizang Haisco Pharmaceutical Co., Ltd** · enrollment: 250 (estimated)

## Conditions studied

- Pruritus

## Interventions

- **DRUG:** HSK21542 tablet
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06290375
- **Lead sponsor:** Xizang Haisco Pharmaceutical Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-03-08
- **Primary completion:** 2024-03-08
- **Final completion:** 2025-04-11
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2024-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06290375

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06290375, "A Study of HSK21542 in a Peritoneal Dialysis Pruritus Population.". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06290375. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*